ESR1 and breast cancer: Finally, this brings into question the consequence of robust PELP1 overexpression observed in ERα positive breast cancers, as well as many hormonal cancers, wherein PELP1 oncogenic function may extend beyond ribosome synthesis and into SR coactivation.